Ionized and total magnesium levels in patients with chronic kidney disease: associated factors and outcomes.
In: Clinical Kidney Journal, Jg. 17 (2024-04-01), Heft 4, S. 1-12
Online
academicJournal
Zugriff:
Background The association between hypo- and/or hypermagnesaemia and cardiovascular (CV) outcomes or mortality has shown conflicting results in chronic kidney disease (CKD) and has been conducted on total magnesium (tMg) levels. Thus, the objectives of the present study were to (i) describe the serum ionized Mg (iMg) concentration in patients at various CKD stages, (ii) measure the correlation between iMg and tMg concentrations, (iii) identify their associated factors and (iv) determine whether serum tMg and/or iMg concentrations are associated with major adverse cardiovascular events (MACE) and mortality before kidney replacement therapy in CKD patients. Methods Chronic Kidney Disease–Renal Epidemiology and Information Network (CKD-REIN) is a prospective cohort of CKD patients with an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m 2 . Baseline iMg and tMg serum concentrations were centrally measured. Adjusted cause-specific Cox proportional hazard models were used to estimate hazard ratios (HRs) for first MACE and for mortality. Results Of the 2419 included patients, median age was 68 years, and the mean eGFR was 34.8 mL/min/1.73 m 2 . Concentrations of serum iMg and tMg were strongly correlated (r = 0.89, P < .001) and were independently associated with eGFR. The adjusted HR [95% confidence interval (CI)] for MACE associated with the baseline serum tMg level was 1.27 (0.95; 1.69) for patients in Tertile 1 and 1.56 (1.18; 2.06) for patients in Tertile 3, relative to patients in Tertile 2. The HR (95% CI) of death according to serum tMg concentration was increased in Tertile 3 [1.48 (1.11; 1.97)]. The adjusted risk for MACE and mortality (all-cause or CV) associated with the baseline serum iMg level was not significantly different between tertiles. Conclusions Our analysis of a large cohort of patients with moderate-to-advanced CKD demonstrated that individuals with higher serum tMg concentrations, although still within the normal range, had a greater likelihood of MACE and mortality. However, serum iMg levels were not associated with these outcomes. [ABSTRACT FROM AUTHOR]
Copyright of Clinical Kidney Journal is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Ionized and total magnesium levels in patients with chronic kidney disease: associated factors and outcomes.
|
---|---|
Autor/in / Beteiligte Person: | Pluquet, Maxime ; Kamel, Said ; Pinho, Natalia Alencar de ; Mansencal, Nicolas ; Combe, Christian ; Metzger, Marie ; Massy, Ziad A ; Liabeuf, Sophie ; Laville, Solène M |
Link: | |
Zeitschrift: | Clinical Kidney Journal, Jg. 17 (2024-04-01), Heft 4, S. 1-12 |
Veröffentlichung: | 2024 |
Medientyp: | academicJournal |
ISSN: | 2048-8505 (print) |
DOI: | 10.1093/ckj/sfae046 |
Schlagwort: |
|
Sonstiges: |
|